Market revenue in 2023 | USD 49.5 million |
Market revenue in 2030 | USD 91.0 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments |
Key market players worldwide | Thermo Fisher Scientific Inc, BD, Danaher Corp, Terumo Corp, STEMCELL Technologies, Bio-Rad Laboratories Inc, Merck KGaA, Agilent Technologies Inc, Corning Inc, Akadeum Life Sciences |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell separation market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 63.84% in 2023. Horizon Databook has segmented the Saudi Arabia cell separation market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of Saudi Arabia cell separation market can primarily be attributed to the various initiatives being undertaken by the government to expand the biotechnology sector in the country. Organizations such as the King Abdullah University of Science and Technology (KAUST) facilitate biotechnology R&D activities in Saudi Arabia.
Key players are expanding into the country to capitalize on the increasing demand for flow cytometry and related products. For instance, in November 2022, Sysmex opened its subsidiary in Saudi Arabia to cater to customers in the country.
Furthermore, increasing private and public partnerships for expanding the biopharmaceutical industry in the country are further anticipated to boost the demand for cell separation products in Saudi Arabia. For instance, in October 2019, Saudi Arabian Investment Authority (SAGIA) signed a MOU with Korea’s GL Rapha Co. to manufacture biological drugs worth USD 320 million in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia cell separation market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia cell separation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account